,i  #aafth ,,congress  #b;d ,session    
,h4 ,r4 #gajd  ,,in ,,the ,,house ,,of  
,,representatives  ,june #d1 #bjbj,ms4  
,kuster of ,new ,hampshire 7for herself 
and ,mr4 ,jeffries7 introduced the      
following bill2 which was referred to   
the ,committee on ,energy and ,commerce 
,a ,,bill  ,to direct the ,secretary of 
,health and ,human ,services to award   
contracts1 grants1 and cooperative      
agreements to expand and enhance        
manufacturing capacity of vaccines and  
vaccine candidates to prevent the spread
 of ,,sars-,co,v-#b and ,,covid-#ai4    
#a4 ,vaccine manufacturing and          
administration capacity  7a7 ,enhancing 
manufacturing capacity  7#a7 ,in general
 ,the ,secretary of ,health and ,human  
,services 7in this section referred to  
as the ,secretary7 acting through the   
,director of the ,biomedical ,advanced  
,research and ,development ,authority   
shall1 as appropriate1 award contracts1 
grants1 and cooperative agreements1 and 
enter into other transactions1 to expand

 and enhance manufacturing capacity of  
vaccines and vaccine candidates to      
prevent the spread of ,,sars-,co,v-#b   
and ,,covid-#ai4  7#b7 ,authorization of
 appropriations ,to carry out this      
subsection1 there are authorized to be  
appropriated such sums as may be        
necessary for fiscal years #bjbj through
 #bjbd1 to remain available until       
expended4  7b7 ,report on vaccine       
manufacturing and administration        
capacity  7#a7 ,in general ,not later   
than ,december #ca1 #bjbj1 the          
,secretary shall submit to the          
,committee on ,energy and ,commerce of  
the ,house of ,representatives and the  
,committee on ,health1 ,education1      
,labor and ,pensions of the ,senate a   
report detailing-- 7,a7 an assessment of
 the estimated supply of vaccines and   
ancillary medical products related to   
vaccine administration necessary to     
control and stop the spread of          
,,sars-,co,v-#b and ,,covid-#ai1        
domestically and internationally2  7,b7 

an assessment of current and future     
domestic manufacturing capacity for     
vaccines or vaccine candidates to       
control or stop the spread of           
,,sars-,co,v-#b and ,,covid-#ai1 vaccine
 candidates1 and ancillary products     
related to the administration of such   
vaccines1 including identification of   
any gaps in manufacturing capacity2     
7,c7 activities conducted to expand and 
enhance manufacturing capacity for      
vaccines1 vaccine candidates1 and       
ancillary medical products to levels    
sufficient to control and stop the      
spread of ,,sars-,co,v-#b and           
,,covid-#ai1 domestically and           
internationally1 including a list and   
explanation of all contracts1 grants1   
and cooperative agreements awarded1 and 
other transactions entered into1 for    
purposes of such expansion and          
enhancement and how such activities will
 help to meet future domestic           
manufacturing capacity needs2  7,d7 a   
plan for the ongoing support of enhanced

 manufacturing capacity for vaccines1   
vaccine candidates1 and ancillary       
medical products sufficient to control  
and stop the spread of ,,sars-,co,v-#b  
and ,,covid-#ai1 domestically and       
internationally2 and  7,e7 a plan to    
support the administration of vaccines  
approved or authorized by the ,food and 
,drug ,administration to control and    
stop the spread of ,,sars-,co,v-#b and  
,,covid-#ai1 domestically and           
internationally1 including ,federal     
workforce enhancements necessary to     
administer such vaccines4  7#b7         
,ancillary medical products ,for        
purposes of this subsection1 ancillary  
medical products includes-- 7,a7 vials2 
7,b7 bandages2  7,c7 alcohol swabs2     
7,d7 syringes2  7,e7 needles2  7,f7     
gloves and other personal protective    
equipment2 and  7,g7 other medical      
products the ,secretary determines      
necessary for the administration of     
vaccines4